Joel Schmillevitch

Joel Schmillevitch

Auto-generated profile, based on publicly available information

Joel Schmillevitch

Santa Casa de São Paulo, Brasil

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 November 2021 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
RSRoberto Gomes da Silva
Roberto Gomes da Silva
MMMaria Luiza Queiroz de Miranda
Maria Luiza Queiroz de Miranda
PBPaulo Eugênio de Araújo Caldeira Brant
Paulo Eugênio de Araújo Caldeira Brant
PSPerla Oliveira Schulz
Perla Oliveira Schulz
MNMaria de Fátima Araujo Nascimento
Maria de Fátima Araujo Nascimento
LSLuiz Arnaldo Szutan
Luiz Arnaldo Szutan
Objective: Identifying significant fibrosis is crucial to evaluate the prognosis and therapeutic interventions in patients with nonalcoholic fatty liver disease (NAFLD). We assessed the performance of acoustic radiation force impulse (ARFI) elastography, APRI, FIB-4, Forns, NFS and BARD scores in determining liver fibrosis in severe obesity. Subjects and methods: A prospective study included 108 patients undergoing bariatric surgery. Liver biopsy specimens were obtained intraoperatively and classified according to the NAFLD Activity Score. Patients were assessed with serological markers and [...] ABSTRACT Objective: Identifying significant fibrosis is crucial to evaluate the prognosis and therapeutic interventions in patients with nonalcoholic fatty liver disease (NAFLD). We assessed the performance of acoustic radiation force impulse (ARFI) elastography, APRI, FIB-4, Forns, NFS and BARD scores in determining liver fibrosis in severe obesity. Subjects and methods: A prospective study included 108 patients undergoing bariatric surgery. Liver biopsy specimens were obtained intraoperatively and classified according to the NAFLD Activity Score. Patients were assessed with serological markers and

1 January 2024 in Arquivos de Gastroenterologia
Verified
Journal Article
Open access
PDF file
JXJoão Batista Xavier
João Batista Xavier
JSJoel Schmillevitch
Joel Schmillevitch
CEChristini Emori
Christini Emori
SUSilvia Uehara
Silvia Uehara
ENEunice Jadriana Nunes
Eunice Jadriana Nunes
MFMaria Lucia Ferraz
Maria Lucia Ferraz
Background: Liver biopsy (LB) is still the gold standard method for assessing hepatic fibrosis (HF), associated diseases, and liver inflammation. Nowadays, noninvasive techniques such as Acoustic radiation force impulse (ARFI) elastography have been introduced instead of liver biopsy. However, there are controversies about the time it should be performed after treatment for hepatitis C virus (HCV).